Concurrent TMPRSS2-ERG and SLC45A3-ERG rearrangements plus PTEN loss are not found in low grade prostate cancer and define an aggressive tumor subset

详细信息    查看全文

• 作者：Silvia Hern&#225 ; ndez ; Alba Font-Tello ; Nú ; ria Juanpere ; Silvia de Muga ; Marta Lorenzo ; Marta Salido ; Lluí ; s Fumadó ; Laia Serrano ; Lluí ; s Cecchini ; Sergio Serrano and Josep Lloreta
• 刊名：The Prostate
• 出版年：2016
• 出版时间：June 15, 2016
• 年：2016
• 卷：76
• 期：9
• 页码：854-865
• 全文大小：1307K
• ISSN：1097-0045

文摘

SLC45A3 is the second most common ERG partner in prostate cancer (PrCa). Coexisting TMPRSS2 and SLC45A3 rearrangements are found in a subset of cases, but the meaning is still unknown.